All filters
Abstracts
Detection of mutations associated with antiretroviral drug resistance from HIV proviral DNA in patients with low-level viremias
P. Ferrer Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Clonal Case Assessments for Participants Failing with Emergent Integrase Resistance in the DAWNING Second Line Study
M. Underwood Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
K156N integrase substitution in combination with 3’PPT resistance mutations against dolutegravir
R. Gruters Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Long-term Efficacy, Safety, and Durability of Ibalizumab-based Regimens in Subgroup of TMB- 202 Participants
H. Jullien Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Residual HIV-1 RNA in 4d on/3d off (ANRS 170 QUATUOR) through W96
S. Lambert Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Switch to ART with BIC/FTC/TAF achieves virological control in patients with low level viremia
I. Santos Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Implementation of HCV- infection treatment programm with DAA in armenia among HIV- infected patients in COVID-19 era
N. Sargsyants Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
HIV and SARS-CoV-2: the interplay of two wicked problems
A. Vandamme Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Eu HIV & Hep Abstracts 2022_56
L. Ramirez Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Prevalence and viral load suppression rate among children and adolescents with dual infections (any two of HIV, HBV, and HCV) in Nnewi, Nigeria
S. Kalu Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Proviral DNA for detection of HIV-1 subtype A drug resistance mutations
D. Turner Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Combined COVID-19 vaccination and hepatitis C virus screening intervention for high-risk populations at a centre for addiction services in Barcelona, Spain
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Combined COVID-19 vaccination and hepatitis C virus and HIV screening intervention for high- risk populations at a mobile testing unit in Madrid, Spain
J. Lazarus Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Community perspectives on self- testing for HIV and HCV in the WHO European region
S. North Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Viral load suppression after three-year Ibalizumab treatment in a multidrug-resistant HIV-1- infected woman: Clinical experience.
I. Santos Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
CASE - HIV+ End-Stage Renal Disease Patient with Immunosuppressive Drug-Drug Interactions Received Successful Transplantation after Ibalizumab Suppressed Switch
S. Sharma Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Clinical course of AIDS with COVID-19 coinfection with prolonged SARS CoV-2 replication despite remdesivir/molnupiravir treatment.
B. Aksak-Wąs Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
A Case of IRIS Syphilis Due to Prozone Effect
Y. Rahman Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Videos
Update on COVID-19 Therapeutics (May 2022 Edition) | Daniel Kuritzkes, MD
Presented at:
COVID-19 Clinical Forum 2022
Slidesets
Update on COVID-19 Therapeutics (May 2022 Edition) - Daniel Kuritzkes, MD
Presented at:
COVID-19 Clinical Forum 2022
Videos
Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience – Part 2 | Fiona Marra, MPharm, MSc
Presented at:
Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022
Videos
Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience - Part 1 | Catia Marzolini, PharmD, PhD
Presented at:
Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022
Videos
Oral Antivirals for COVID-19: Drug-Drug Interactions as a Manageable Risk | David Burger, PharmD, PhD
Presented at:
Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022